Drugs / Succinic Acid
last change Sep 2024 re-read 2 minutes ago

Succinic Acid

Small molecule

Developed for
brain injury
Investigated by
POLYSAN Scientific & Technological Pharmaceutical Company

Trials 1 · a red edge is where a trial was stopped

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04631484 Nov 2020 → May 2024 brain injury POLYSAN Scientific & Technological Pharmaceutical Company Completed No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Succinic Acid ClinicalTrials.gov intervention name — accepted as the source's own label NCT04631484
Known as Amber acid ChEMBL registry synonym — accepted as the source's own label CHEMBL576
Known as Dihydrofumaric acid ChEMBL registry synonym — accepted as the source's own label CHEMBL576
Known as E363 ChEMBL registry synonym — accepted as the source's own label CHEMBL576
Known as FEMA NO. 4719 ChEMBL registry synonym — accepted as the source's own label CHEMBL576
Known as NSC-106449 ChEMBL registry synonym — accepted as the source's own label CHEMBL576
Known as Succinicum acidum ChEMBL registry synonym — accepted as the source's own label CHEMBL576
Modality Small molecule CHEMBL576